ADPT - Adaptive Biotechnologies Q1 2024 Earnings Preview
2024-05-06 17:35:57 ET
More on Adaptive Biotechnologies
- Adaptive Biotechnologies: A Post Earnings Assessment
- Adaptive Biotechnologies announces conclusion of strategic review, expects Q1 revenue between $41M and $43M
- Adaptive Biotechnologies GAAP EPS of -$0.48 misses by $0.15, revenue of $45.78M misses by $2.68M